Skip to main content

Table 1 Clinicopathological characteristics of all patients

From: Prediction of neoadjuvant chemotherapeutic efficacy in patients with locally advanced gastric cancer by serum IgG glycomics profiling

Characteristics

Total (%)

Non-response group (%)

Response group (%)

P value

Age

0.884

 ≤ 60

25 (51)

13 (54)

12 (48)

 

 > 60

24 (49)

11 (46)

13 (52)

 

Sex

0.924

 Male

34 (69)

16 (67)

18 (72)

 

 Female

15 (31)

8 (33)

7 (28)

 

Site

0.291

 U

11 (22)

6 (25)

5 (20)

 

 M

15 (31)

8 (33)

7 (28)

 

 L

16 (33)

9 (38)

7 (28)

 

 Overlapping

7 (14)

1 (4)

6 (24)

 

Histology

0.479

 Adenocarcinoma

11 (22)

4 (17)

7 (28)

 

 SRC

6 (12)

4 (17)

2 (8)

 

 Other

32 (65)

16 (67)

16 (64)

 

Regimen

0.686

 DOS

10 (20)

6 (25)

4 (16)

 

 XELOX

23 (47)

11 (46)

12 (48)

 

 Other

16 (33)

5 (21)

8 (32)

Â